Powered by Axial Data

Top Pharmaceuticals Private Equity Funds

Explore 201 Pharmaceuticals Private Equity Funds that source acquisition and investment opportunities on Axial’s M&A platform.

Axial Insights

Pharmaceuticals Private Equity Funds

201

Active Firms

14,250

TTM Deal Inquiries

$3M-$19M

Core Revenue Range

$800K-$4M

Core EBITDA Range


Florida 14%
California 11%
Texas 10%
New York 7%
New Jersey 4%

Focus: Control Investments | Capital Source: Committed Capital | Operating Approach: Scale & Exit

Showing 141-160 of 201 Private Equity Funds

Sorted by recent activity

Altura Capital

Actively Sourcing Deals
Lower middle market private equity and private debt investment firm. Industries we invest in include business services, consumer goods, healthcare and specialty manufacturing. We provide equity (majority and minority) and mezzanine debt capital.

Recent Transactions

This member has no reported closed transactions.

Aquitaine Capital

Actively Sourcing Deals
We partner with founders and family-owned companies in their next stage of growth, taking businesses from good to great. We are not just flippers, consolidators, or cost-cutters. We want your business and your team to survive and thrive for the long run.

Recent Transactions

This member has no reported closed transactions.

EnTrust Global

Actively Sourcing Deals
We are a $16 bn asset management firm with offices globally. We make investments across capital structure, with a focus on hybrid capital. We prefer businesses with an EV over $50 mn, though our sweet spot is anywhere from $200 mn to $500 mn.

Recent Transactions

This member has no reported closed transactions.

Lineage Capital

27 Total Closed Deals
A unique model—tailored to the needs of owner-managers.Lineage was founded on the core values of trust, respect, teamwork, and commitment—ideals that provide a foundation for our strong partner relationships. For business owners who share these values, the uncommon structure of a Lineage partnership can be a way to comfortably achieve short- and long-term business and personal objectives.For nearly two decades, we’ve partnered with owner-managers who desire liquidity while continuing to benefit from the future financial success of their business. Our investment model allows…

Recent Transactions

View All
  • Jun 2024 Invested in GIK Acoustics
  • Feb 2024 Invested in Flutterbee Education Group
  • Feb 2024 Invested in Quality Glass & Mirror
  • Oct 2023 Acquired Concept Agritek
Kingswood Capital is a private investment firm primarily focused on businesses that are undergoing varying degrees of operational, financial or market-driven change. In addition to access to capital, we bring relevant industry relationships and a broad network of internal and external operating resources that can strengthen the business and enhance value. Based in Los Angeles, we are a cohesive team of senior professionals from industry leading private equity firms with a history of success. We have extensive experience with complex transactions and difficult situations, where we provide…

Recent Transactions

View All
  • May 2025 Invested in The Vitamin Shoppe
  • May 2025 Acquired OneX
  • Feb 2025 Invested in InfoTree Global Solutions
  • Nov 2024 Acquired Branding Iron

CVC Capital Partners

15 Total Closed Deals
Global Private Equity and Growth Capital FirmCVC manages capital on behalf of over 300 institutional, governmental and private investors worldwide. Over the years, we have secured commitments of more than US$71 billion in funds from our investors (including CVC Credit Partners). The capital of our investors is committed for ten years or more to closed-end funds that we manage on their behalf.

Recent Transactions

View All
  • Aug 2017 Provided debt financing to Wastewater Specialities, LLC
  • Jun 2017 Provided debt financing to Shannon Specialty Floors, LLC
  • May 2017 Provided debt financing to TWMA
  • Jun 2016 Provided debt financing to The Legacy Companies

Stop Browsing. Start Transacting.

Join 20,000+ members who source deals, connect with counterparties, and close transactions on Axial.

Inverness Graham

11 Total Closed Deals
Headquartered in Newtown Square, PA, Inverness Graham is an operationally focused private investment firm that has raised over $1 billion of capital since its inception. Inverness Graham acquires innovative tech-enabled manufacturing, service and software companies.Our approach is as unique as our heritage. Founded by senior executives of the Graham Group, an alliance of independent operating businesses, investment firms and philanthropic entities, we bring unparalleled resources developed over a 50-year operating history to support our portfolio companies.Inverness Graham partners with…

Recent Transactions

View All
  • Mar 2023 Acquired Innovia Medical
  • Jan 2023 Acquired Treat Planet
  • Aug 2022 Acquired Custom Agronomics
  • Feb 2022 Acquired Concord Servicing
Starboard Capital Partners is a private equity firm that sponsors and invests in lower middle market companies, with values ranging from $10 million to $250 million. We participate with our network of high net worth, family office, and institutional fund co-investors to partner with management teams and entrepreneurs who are looking to accelerate the growth of their companies. Starboard is actively involved in leveraged buyouts, growth equity investments, and recapitalizations. Most importantly, we actively listen to business owners and look to match our knowledge and capital resources to…

Recent Transactions

View All
  • Jun 2015 Invested in QDiscovery
  • Mar 2015 Invested in Brite-Line Technologies
  • Oct 2011 Acquired PureRED (previously GA|PRC Group)
  • Jul 2011 Invested in JPC Holdings, LLC (Jersey Precast)

ICV Capital Partners

10 Total Closed Deals
Founded in 1998, ICV Capital Partners is a private investment firm focused on making equity investments in America's smaller middle-market companies. ICV seeks to generate long-term capital appreciation by investing in companies with revenues between $25 million and $200 million.ICV targets companies that have a history of stable cash flows and offer the prospect of meaningful growth. These companies are leaders in their markets with highly-defensible positions. They have strong and proven management teams that are eager to invest in their company.ICV Growth Partners was launched in 2009 to…

Recent Transactions

View All
  • Apr 2011 Acquired Cargo Airport Services
  • Jan 2011 Acquired Stauber Performance Ingredients
  • Oct 2010 Acquired Press-A-Print International, LLC
  • Oct 2010 Acquired Public Financial Management, Inc.
Graham Healthcare Capital (GHCC) employs a Berkshire Hathaway-like model, providing permanent capital solutions to acquire middle-market healthcare companies. This strategy allows for decision-making with a long-term mindset that is best for the ongoing viability of the company. Our principals bring significant healthcare operational expertise to our partnerships with business owners. Graham Healthcare Capital is an affiliate of Graham Healthcare Group which is owned and managed by Graham Holdings Company (NYSE:GHC). GHC is a diversified holding company whose operations include educational…

Recent Transactions

View All
  • Aug 2023 Acquired Allegheny Health Network
  • Aug 2023 Acquired CSI Pharmacy
  • Aug 2023 Acquired Weiss Medical
  • Aug 2023 Acquired Darby

Oroco Capital

8 Total Closed Deals
Oroco Capital is a private equity investment firm. Our strategy is to buy great businesses in our target industries and build value through both internal growth and acquisitions, resulting in excellent returns for our investors. The team at Oroco has completed over 50 deals totaling over $5.0B. We developed a unique capital structure and have capital commitments from family offices, wealthy individuals and small institutions. In addition, Oroco has formed a strategic alliance with a private investment firm that allows Oroco to partner on investments that vary in size and type. Our strategy is…

Recent Transactions

View All
  • Jan 2019 Invested in Maridata
  • Jan 2019 Acquired FirstMark Materials
  • Feb 2018 Acquired FirstMark Foundations
  • Feb 2017 Acquired FirstMark Construction

Downing Capital

7 Total Closed Deals
Catalyzing creativity: equipping our leaders to actualize their visions. People - The quality of the team ultimately determines whether a new business succeeds or fails. Our experienced in-house talent acquisition function helps structure founding teams, devise talent strategies, and execute on searches.Technology - We have relationships with experienced CTOs, software engineers, and technical recruiters to enable portfolio companies to develop products at a lower cost and to help overcome technical challenges that arise.Funding - Founders often turn to friends and family to pull together the…

Recent Transactions

View All
  • Jan 2025 Invested in Bloomwell
  • Apr 2024 Invested in Immersiv Health
  • Apr 2024 Invested in Maro
  • Jan 2024 Invested in Wellnest Fertility

Tuckerman Capital

7 Total Closed Deals
Tuckerman Capital is a private investment firm that works with Deal Partners (experienced executives and Independent Sponsors) to invest in and build exceptional small companies that deliver innovative solutions for the long-term with enterprise values typically ranging from $10 million to $75 million.

Recent Transactions

View All
  • Oct 2010 Acquired Promo Seeds, Ltd.
  • Oct 2010 Acquired Shield Pack, LLC
  • Oct 2010 Acquired Solidscape, Inc.
  • Oct 2010 Acquired Wohler Technologies, Inc.

Berenson Capital

7 Total Closed Deals
Berenson Capital is a sector-focused private equity firm investing in Software & Tech-Enabled Services businesses with a minimum of $5 million of annual revenues.

Recent Transactions

View All
  • Aug 2023 Acquired Device42 Inc.
  • Aug 2023 Acquired TI Health
  • Aug 2023 Acquired StratEx
  • Jun 2021 Acquired Practice Insight

Cathay Capital

5 Total Closed Deals
Cathay Capital Group is a global investment firm supporting companies at all stages throughout North America, Asia, Europe and Africa. By helping navigate the opportunities of globalization and sustainable transformation, Cathay is the partner of choice for companies aspiring to lead markets and make a positive impact. Its global platform connects people – from investors and entrepreneurs to management teams and leading corporations – across continents to share knowledge, the tools to scale, and achieve the extraordinary. Founded in 2007 with a strong entrepreneurial heritage, Cathay…

Recent Transactions

View All
  • Jan 2025 Acquired Bioptimus
  • Jan 2025 Acquired Nelly
  • Dec 2024 Acquired Aqemia
  • Oct 2024 Acquired Cryptio

Cresset Partners

5 Total Closed Deals
Cresset Private Capital investing team makes direct investments in operating companies where we have experience. We focus on long term partnerships with like-minded entrepreneurs, founders, and management teams. We believe in long-term, flexible, and patient capital avoiding misalignment, friction and unfavorable fee structures, which can produce inefficient results for business owners and investors.

Recent Transactions

View All
  • Aug 2023 Acquired WestMONROE
  • Aug 2023 Acquired Churchill from Nuveen
  • Aug 2023 Acquired Selby Lane
  • May 2023 Acquired TRUE Capital Management

Alpine Investors

5 Total Closed Deals
Alpine Investors is a people-driven private equity firm specializing in investing in software and services businesses. They focus on majority buyouts and corporate carve-outs, particularly targeting companies with recurring revenue models that are undergoing transitions and scaling. Alpine Investors is committed to building enduring businesses by inspiring growth in people and creating exceptional workplaces. Their investment strategy includes hiring executives to drive business transformation, and they have developed platforms like the Alpine Software Group to buy, build, and operate…

Recent Transactions

View All
  • May 2022 Acquired DRMP
  • Apr 2022 Acquired AirDNA
  • Jan 2021 Acquired Cedar Solutions Group
  • Nov 2020 Acquired Astra Service Partners
Fulcrum Capital Partners (“Fulcrum”) is an independent private equity firm focused on the Canadian lower-middle marketWe generally invest in a variety of industries including manufacturing, services, distribution and logistics, and consumer productsIn addition to providing capital, we add value in multiple areas including governance, strategy, acquisitions, succession, operations and capital structuresFulcrum is owned by its management and we personally invest in every portfolio companyInvested and raised nearly $1 billion in 55 platform companies since 1998Currently investing out of our…

Recent Transactions

View All
  • Oct 2024 Invested in Sunco Foods
  • Mar 2023 Invested in FE Ingredients
  • Oct 2022 Invested in EQI
  • Dec 2021 Invested in B. Horticulture
Public Pension Capital is a middle-market private equity fund that invests in Industrial Services, Business & Financial Services and Healthcare Services. We are focused on businesses in North American with approximately $5M-$30M EBITDA.The PPC team is led by former KKR partners Perry Golkin and Mike Tokarz. The principals of PPC have worked together for a combined 70+ years with a successful investment record over that time.Our experience allows us to add value to portfolio companies through industry relationships, new customer introductions, strategy development, regulatory understanding,…

Recent Transactions

View All
  • Jun 2019 Acquired Private Client Resources, LLC
  • May 2019 Acquired Bluegrass Ingredients
  • Mar 2017 Acquired Viteos Fund Services LLC
  • Mar 2017 Acquired Inframark, LLC

Tucker Partners

3 Total Closed Deals
TUCKER PARTNERS is a private investment firm. We focus on the acquisition, management and growth of middle market businesses. Tucker Partners targets established businesses to acquire. Our goal is to provide attractive exit options for owners of privately held businesses and for divestitures of corporate divisions. The Acquisition Criteria section describes our interests, which are focused on specialized distribution companies as well as light manufacturing/processing operations. We can be flexible in our approach, which allows for a fair and tax-efficient value for the seller. We pool our…

Recent Transactions

View All
  • Nov 2011 Acquired AIrcraft Fasteners International
  • Nov 2011 Acquired Golden State Medical Supply
  • Nov 2011 Acquired Speciality Dynamics

Frequently Asked Questions

How are Private Equity Funds in this directory ordered?

Firms in the Pharmaceuticals Private Equity Funds directory are ordered based on recent deal activity on Axial. The default order reflects observed market signals rather than a subjective ranking of firm quality.

What information is included in each Private Equity Fund profile?

Each profile provides information about the firm’s areas of focus, transaction criteria, and relevant activity on Axial’s M&A platform. Together, these details provide a clearer view of where a firm is active and the types of companies and opportunities most relevant for it.

What company sizes are most common for Pharmaceuticals Private Equity Funds?

Based on activity on Axial’s M&A platform, the core revenue range for Pharmaceuticals Private Equity Funds is $3M-$19M, with a core EBITDA range of $800K-$4M. Company size can be an important indicator of fit, as firms often concentrate their experience, resources, and transaction activity within particular segments of the market.

How important is Life Sciences experience when evaluating Private Equity Funds?

Relevant Life Sciences experience can be an important consideration when evaluating a firm. Familiarity with the sector can provide a stronger understanding of its business models, market dynamics, valuation considerations, and transaction environment. The 201 firms included in this directory provide a starting point for identifying firms with relevant experience and activity in Life Sciences.

Do all Private Equity Funds in this directory focus exclusively on Life Sciences?

Not necessarily. Many firms are active across multiple industries, so inclusion in the Pharmaceuticals Private Equity Funds directory reflects relevant experience or activity in Life Sciences, rather than an exclusive sector focus. Individual profiles provide additional context on each firm’s areas of focus and activity within the sector.

How do I compare Private Equity Funds with experience in Life Sciences?

When comparing Private Equity Funds with experience in Life Sciences, consider factors such as size range, geographic reach, and recent transaction activity. These characteristics vary across the 201 firms included in the directory and can help identify firms that align with your needs.

How do I connect with Pharmaceuticals Private Equity Funds?

Axial can help you identify and connect with firms based on your objectives and what you are looking to accomplish. The process varies depending on your role and transaction needs. If you are interested in connecting with firms in the Pharmaceuticals Private Equity Funds directory, you can request information here.


Want to Keep Exploring?

Enter your details to access all firm profiles.

Let us curate Relevant Introductions.

Rather than a one-off introduction to company, work with an Axial Exit Consultant to find the best options from our network of 2,500 M&A advisors — at no cost to you.

Companies sold using Axial Advisor Finder:

Get Introduced to the Right Advisors

This service is complimentary and all information is confidential. Looking to learn more? Complete the form above.

By providing telephone number and submitting the form you are consenting to be contacted by SMS text message. Message & data rates may apply. Reply STOP to opt of further messaging.

We've Received Your Request

A member of our team will follow up to coordinate next steps.

Explore Axial
Template